-
EP1804782
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1804782
| EP1804782 - USE OF (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE FOR TREATING INFLAMMATORY BOWEL DISEASE [Right-click to bookmark this link] | Status | The application has been refused Status updated on 23.04.2010 Database last updated on 13.11.2024 | Most recent event Tooltip | 23.04.2010 | Refusal of application | published on 26.05.2010 [2010/21] | Applicant(s) | For all designated states Aventis Pharmaceuticals Inc. 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807-2854 / US | [N/P] |
| Former [2007/28] | For all designated states Aventis Pharmaceuticals Inc 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807-2854 / US | Inventor(s) | 01 /
SCHEYER, Richard, D. 3415 Round Hill Road Branchburg, NJ 08876 / US | 02 /
STYREN, Scot, D. 117 Sleepy Hollow Drive Niantic, CT 06357 / US | [2007/28] | Representative(s) | Morel-Pécheux, Muriel Sanofi Département Brevets 54, rue La Boétie 75008 Paris / FR | [N/P] |
| Former [2007/28] | Morel-Pécheux, Muriel Aventis Pharma SA, 20, avenue Raymond Aron 92160 Antony Cedex / FR | Application number, filing date | 05812243.3 | 18.10.2005 | [2007/28] | WO2005US37161 | Priority number, date | US20040620255P | 19.10.2004 Original published format: US 620255 P | [2007/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006044741 | Date: | 27.04.2006 | Language: | EN | [2006/17] | Type: | A1 Application with search report | No.: | EP1804782 | Date: | 11.07.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.04.2006 takes the place of the publication of the European patent application. | [2007/28] | Search report(s) | International search report - published on: | EP | 27.04.2006 | Classification | IPC: | A61K31/165, A61P1/00, A61P29/00 | [2007/28] | CPC: |
A61K31/165 (EP,US);
A61K31/167 (KR);
A61K31/277 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P29/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/28] | Extension states | AL | 21.05.2007 | BA | 21.05.2007 | HR | 21.05.2007 | MK | 21.05.2007 | YU | 21.05.2007 | Title | German: | VERWENDUNG VON (Z)-2-CYANO-3-HYDROXY-BUT-2-ENSÄURE-(4'-TRIFLUOROMETHYLPHENYL)-AMID ZUR BEHANDLUNG ENTZÜNDLICHER DARMERKRANKUNGEN | [2007/28] | English: | USE OF (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE FOR TREATING INFLAMMATORY BOWEL DISEASE | [2007/28] | French: | EMPLOI DU (4'-TRIFLUOROMETHYLPHENYL)AMIDE DE L'ACIDE (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIQUE DANS LE TRAITEMENT D AFFECTIONS ABDOMINALES INFLAMMATOIRES | [2007/28] | Entry into regional phase | 21.05.2007 | National basic fee paid | 21.05.2007 | Designation fee(s) paid | 21.05.2007 | Examination fee paid | Examination procedure | 21.05.2007 | Examination requested [2007/28] | 03.07.2007 | Amendment by applicant (claims and/or description) | 30.08.2007 | Despatch of a communication from the examining division (Time limit: M06) | 04.03.2008 | Reply to a communication from the examining division | 29.07.2008 | Despatch of a communication from the examining division (Time limit: M04) | 04.12.2008 | Reply to a communication from the examining division | 03.12.2009 | Application refused, date of legal effect [2010/21] | 03.12.2009 | Date of oral proceedings | 07.01.2010 | Despatch of communication that the application is refused, reason: substantive examination [2010/21] | 07.01.2010 | Minutes of oral proceedings despatched | Fees paid | Renewal fee | 24.10.2007 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 13.10.2009 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US5780592 (MUELLNER STEFAN [DE], et al) [X] 1,3-5 * column 5, line 41 * * example 1 * * claim 3 *; | [X]WO9954286 (WAYNE HUGHES INST [US]) [X] 1,2 * claims 1,18 * * table 1 *; | [A]WO02080897 (AVENTIS PHARMA INC [US], et al) [A] 1-5 * the whole document *; | [A]WO2004024676 (SCHEBO & REG [DE], et al) [A] 1-5 * figure 2b * * page 9, paragraph 1 * * page 16, paragraph L * * claim 11 *; | [PA] - STEINHILBER D, "Pharmacology of immunosuppressive agents", PHARMAZIE IN UNSERER ZEIT 2005 GERMANY, (2005), vol. 34, no. 4, ISSN 0048-3664, pages 276 - 281, XP002365151 [PA] 1-5 * page 280, column R * * figure 9 * DOI: http://dx.doi.org/10.1002/pauz.200500127 | [AD] - KIMURA K ET AL, "Concurrence of inflammatory bowel disease and multiple sclerosis", MAYO CLINIC PROCEEDINGS 2000 UNITED STATES, (2000), vol. 75, no. 8, ISSN 0025-6196, pages 802 - 806, XP009060726 [AD] 1-5 * the whole document * DOI: http://dx.doi.org/10.4065/75.8.802 | Examination | - PRAPAJATI D.N. ET AL, "leflunomide treatment of Chron's disease patients intolenrant to standard immunomodulator therapy", JOURNAL OF CLINICAL GASTROENTEROLOGY, (2003), vol. 37, no. 2, pages 125 - 128, XP009060723 |